Holiday greetings from the Genevia Technologies team!
The year 2020 is coming to its end, finally! Looking back, we see yet another year of exciting bioinformatics projects across life sciences — just more of them than ever before! We can only thank our customers and collaborators for keeping us busy despite the challenges affecting us all. Let us reflect on some of the highlights of the year!
Expanding our team
More projects call for more people — we have had the pleasure to welcome seven new team members among us this year! Our tech team grew with three new scientific project managers, Felipe, Jelena and Maria, and with one new bioinformatician, Alastair. To support the company’s growth, three new colleagues also joined our business team: Aleksandra, Anni and Venla.
Our bioinformatician Tommi Rantapero finished his PhD in computational cancer genomics — once again: congrats, Tommi! We are also proud to note that our team members published 12 new papers, in addition to recent papers we have helped our customers publish on topics such as extracellular nanovesicles, hepatocellular carcinoma, Alzheimer's disease, schizophrenia, psychopathy, endometriosis, NGS-based strain verification and crop protection!
Deeper analyses, deeper partnerships
We have been fortunate to work with researchers from almost every corner of biology and biomedicine, and each project leaves us with deeper expertise and a curiosity to learn even more. A clear trend this year has been the increase in complementing omics analyses with machine learning to predict phenotypes and clinical endpoints from large molecular and clinical data — something that we are excited to work on even more next year!
We had the pleasure to sit down with some of our customers and discuss what a project with Genevia looks like from the customer's perspective. Thank you professor Giuseppe Masucci from the Karolinska Institute and professor Juha Kantanen from Natural Resources Institute Finland for your thoughts! We are about to publish other cases as well, so stay tuned!
We also interviewed the founders of our company, CSO Matti Nykter and CEO Antti Ylipää. To learn more about the story of Genevia Technologies and the researchers who founded it, take a look at the published interviews:
- An interview with professor Matti Nykter: CSO and dedicated researcher
- An interview with Antti Ylipää: Oncology researcher turned CEO
Merry Christmas and Happy New Year 2021!
From the bottom of our hearts, we want to thank our clients and collaborators for a very interesting year! Let us all hope 2021 will be a better one in all ways possible!
P.S. If you are planning next year’s research projects, now is the best time to secure required bioinformatics resources – take a look at our end-of-year sale!
Genevia's CEO Antti Ylipää in Christmas mood with office dog Luna